Allergy and Asthma Proceedings

Papers
(The median citation count of Allergy and Asthma Proceedings is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
For the Patient86
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination75
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery43
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist34
Impact of steroids on the immune profiles of children with asthma living in the inner-city29
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis27
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis25
Venom allergen immunotherapy24
Future directions in allergen immunotherapy23
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study22
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children21
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks20
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being20
Operationalizing shared decision making in clinical practice19
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii19
For the Patient19
TEV/FEV3 as a coherent metric of small airway dysfunction in childhood asthma18
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 202217
For the Patient17
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes16
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity15
Evaluation and management of chronic cough in adults15
For the Patient14
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-1914
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy13
Treatment strategies for postviral olfactory dysfunction: A systematic review13
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy13
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department12
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis12
A 33-year-old man with a history of recurrent pneumonia presenting with hypoxemic respiratory failure12
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course12
Navigating the management complexity in long-term asymptomatic immunodeficiency11
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics11
For the Patient11
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome11
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs11
For the Patient11
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii10
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment10
Diagnostic utility of basophil CD203c expression in β-lactam allergy10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities10
For the patient10
Effects of mechanical washing and drying on the removal of pet allergens10
A tribute to allergy and immunology fellowship training program directors and to the fellows they train10
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention9
Diagnostic value of YKL-40 for patients with asthma: A meta-analysis9
Evaluation of atopic diseases in patients with allergic contact dermatitis9
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy9
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible9
Effect of COVID-19 on hereditary angioedema activity and quality of life9
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab9
Guidelines for management of hereditary angioedema: What is new? What is missing?9
Metal implant allergy: A retrospective cohort analysis at a university allergy practice8
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study8
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema8
Paucigranulocytic asthma: Do sputum macrophages matter?8
Primary Immunodeficiency: Specific antibody deficiency with normal IgG8
Food-induced anaphylaxis in early childhood and factors associated with its severity8
Clinical features of anaphylaxis in children8
Benralizumab in the management of rare primary eosinophilic lung diseases8
Treatment options for chronic rhinosinusitis with nasal polyps8
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives8
The association of timothy grass allergy and cat ownership on cat sensitization8
Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist8
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii8
Hematopoietic stem cell transplantation for primary immunodeficiency8
Cost-effectiveness of school integrated pest management and air filtration in students with asthma8
Overview of secondary immunodeficiency8
The long COVID syndrome: A conundrum for the allergist/immunologist8
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy7
Safety of ciclesonide in children with asthma: A review of randomized controlled trials7
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization7
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-27
Curcumin does not significantly affect immediate skin tests7
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab7
Caregiver perceptions and attitudes associated with oral immunotherapy on social media7
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH7
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center7
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization7
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber7
For the Patient7
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience6
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic6
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis6
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort6
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis6
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)6
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience6
Assessing cross-reactivity in allergen immunotherapy6
Abstracts presented at the Eastern Allergy Conference, June 3‐6, 2021, Palm Beach, Florida6
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis6
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan6
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?6
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study6
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination5
Peanut allergy in an adult following cardiac transplant from a non-atopic donor5
COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications5
Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience5
Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis5
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema5
The immunologic response to severe acute respiratory syndrome coronavirus 25
Genetically-determined defects of T cell development5
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis5
A masquerade of recurrent anaphylaxis5
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease5
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis5
Impact of perinatal risk factors on pediatric asthma: A systematic review and meta-analysis5
Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy5
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria5
For the patient5
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida5
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study5
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis5
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors5
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan5
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma5
Immunodeficiency: Burden of Illness5
Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study4
Treatment options for moderate to severe atopic dermatitis4
Expanding horizons of omalizumab: New frontiers in asthma and beyond4
A review of allergen immunotherapy in asthma4
Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema4
Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment4
Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy4
Clinical predictors of breakthrough reactions during initial rapid drug desensitizations to platinum chemotherapeutics4
Peptide immunotherapy for aeroallergens4
Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines4
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?4
Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies4
The COVID-19 impact on severe uncontrolled asthma costs and biologic use4
Idiopathic anaphylaxis: Diagnosis and management4
A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children4
The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level4
Integrating innovation and shared decision-making in allergy and immunology practice4
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol4
Successful rapid liposomal amphotericin B desensitization in pediatric case series4
Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease4
Anaphylaxis: Long-term management and resources4
Cat allergy in children and the effect of the COVID-19 pandemic4
Clinical implications of asthma endotypes and phenotypes4
Atopic dermatitis: Best of guidelines and yardstick4
For the patient4
For the Patient4
Diagnosis of ciprofloxacin hypersensitivity improves by incorporating MRGPRX2 in basophil activation test3
The effect of the socioeconomic status on the measurement of asthma control3
Allergy immunotherapy for allergic fungal respiratory diseases3
Management and referral patterns for new-onset chronic cough in primary care patients3
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma3
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis3
United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy3
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes3
For the patient3
Capturing total steroid burden in patients with atopic dermatitis and asthma3
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab3
Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications3
The utility of shared decision making in the management of hereditary angioedema3
Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis3
Evaluation of direct oral provocation test results in mild cutaneous reactions to cephalosporins in children3
Oral immunotherapy with sunflower seed butter and a review of seed allergy3
Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing3
Accelerated/rush allergen immunotherapy3
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose3
Interaction between asthma and overweight/obesity on cancer results from the National Health and Nutrition Examination Survey 2005‐20183
The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist3
The complexities of allergic diseases continue to challenge the allergist-immunologist3
Selective immunoglobulin E deficiency and its association with autoimmune and autoinflammatory diseases3
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches3
Assessment of mask use on oxygen saturation in adults and children with asthma3
Health disparities investigated in a primary care penicillin allergy removal pathway3
Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance3
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease3
Allergic comorbidities in fibromyalgia3
Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings3
Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts2
Early-life risk factors for recurrent wheezing in preschool children: A meta-analysis of 15 cohort studies2
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS2
Immunodeficiency: Complement disorders2
Pearls and pitfalls in food protein-induced enterocolitis syndrome (FPIES)2
Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure2
Appraisal of the evidence linking hereditary α-tryptasemia with mast cell disorders, hypermobility and dysautonomia2
Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience2
Do commercial dog extracts cross-react with Felis domesticus allergen 12
Allergic diseases in children: A continuing challenge for the Allergist-Immunologist2
From diagnosis to desensitization in immediate hypersensitivity reactions to both oral and parenteral iron salts2
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study2
Dose-response studies of methylated and nonmethylated CpG ODNs from Bifidobacterium longum subsp. infantis for optimizing Treg cell stimulation2
Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate sub2
Impact of baseline body mass index on asthma incidence in middle-aged and elderly populations: A prospective analysis from China2
SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD2
Idiopathic non-mast cell angioedema: Treatment insights from global experts2
Abstracts presented at the Eastern Allergy Conference May 30‐June 2, 2024, Palm Beach, Florida2
Female sex as a risk factor for penicillin drug allergy in the inpatient setting2
Health disparities in hymenoptera venom allergy management2
The relationship between childhood atopic dermatitis and asthma in an under resourced community2
Pediatric sublingual allergen immunotherapy2
Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up2
Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist2
Single-bag rapid drug desensitization for chemotherapeutic hypersensitivity reactions: A single-center experience2
For the Patient2
Angioedema without urticaria: Diagnosis and management2
Risk factors predisposing children to transient hypogammaglobulinemia of infancy2
Review of efficacy of ciclesonide for the treatment of asthma in children2
Relationship between autoimmune diseases and serum basal immunoglobulin E levels in patients with common variable immunodeficiency2
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease2
To test or not to test: Lessons learned from screening infants for peanut allergy2
Real world use of peanut component testing among children in the Chicago metropolitan area2
Biologic treatment discontinuation in severe asthma: A real-life study on factors influencing clinical remission and physician decision-making2
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management2
Evaluation and management of adverse reactions to the COVID-2019 vaccines2
Prognosis of food-induced anaphylaxis in children: A single-center real-life study2
Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children2
Current and emerging therapies for eosinophilic esophagitis2
Association of EDN levels in patients with asthma and correlation with FEV1%: A meta-analysis2
The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency2
Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes2
The challenge of neurologic disease for the allergist/immunologist2
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities2
0.051506996154785